Drugs Made In America Acquisition II Corp. (DMII) Current Assets (2024 - 2026)

Drugs Made In America Acquisition (DMII) has reported Current Assets for 3 consecutive years, with $217823.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Assets changed N/A year-over-year to $217823.0 in Q2 2026; TTM through Jun 2026 was $217823.0, a N/A change from a year earlier, with the FY2025 full-year figure at $26037.0, down 56.32% from the prior year.
• Current Assets was $217823.0 for Q2 2026 at Drugs Made In America Acquisition, up from $26037.0 in the prior quarter.
• Over five years, Current Assets peaked at $896356.0 in Q3 2025 and troughed at $26037.0 in Q4 2025.
• A 3-year average of $299957.8 and a median of $138719.0 in 2024 frame the typical range for Current Assets.
• The widest YoY moves for Current Assets: up 56.32% in 2025, down 56.32% in 2025.
• Over 3 years, Current Assets stood at $59615.0 in 2024, then sank by 56.32% to $26037.0 in 2025, then soared by 736.59% to $217823.0 in 2026.
• The last three Current Assets figures came in at $217823.0 (Q2 2026), $26037.0 (Q4 2025), and $896356.0 (Q3 2025), per Business Quant data.